FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

Celltrion Healthcare introduces a biosimilar version of Humira called Yuflyma, in the US

Bristol Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal to Expand In Vivo Cell Therapy Portfolio

FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

Spero Shells Out Over $1B For Innovent’s Autoimmune Antibody

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

Insilico Joins Hands With CDMO Bora in AI Drug Discovery Deal Worth $2.5B

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease